{"classes": ["TEMP", "SOFT", "STIME", "MOL", "FFM"], "annotations": [["mRNA lipid nanoparticle phase transition\nThe repository contains input files and data from the manuscript: Trollmann, Marius F.W. and Bo ckmann, Rainer A. \"mRNA lipid nanoparticle phase transition\", Biophysical Journal (2022) https://doi.org/10.1016/j.bpj.2022.08.037 > Periodic membrane patches Equilibrated structures, .mdp and .top files for the simulations of the periodic Comirnaty membrane patches. (microsecond   us) >> periodic patches/low ph/single patch: ~ System A: Three replicas (4.1 us, 3.0 us and 3.0 us) of the self-assembled Comirnaty lipid mixture with the protonated aminolipid >> periodic patches/low ph/quad patch: System B: A quadruplicated system A patch simulated for 1.0 us >> periodic patches/dspc chol: System C: Binary membrane including DSPC and 43mol% cholesterol >> periodic patches/neutral ph: System D: A deprotonated system B patch simulated for 0.633 us >> periodic patches/mrna selfassembly: System E: Structures of the self-assembled Comirnaty lipid mixture with the modified mRNA strand + periodic patches/mrna selfassembly/selfassembly: Structures of the mRNA-lipid mixture after self-assembly with protonated aminolipids + periodic patches/mrna selfassembly/set1: Quadruplicated simulation systems after deprotonation of distant aminolipids (set 1, see paper) + periodic patches/mrna selfassembly/set2: Quadruplicated simulation systems after deprotonation of random aminolipids (set 2, see paper) + periodic patches/mrna selfassembly/set3: Simulation systems after deprotonated of all aminolipids (systems were not quadruplicated) (set 3, see paper) > Lipid nanoparticles Equilibrated structures, .mdp and .top files for the simulations of the lipid nanoparticles. (microsecond   us) >> nanoparticles/lnp nopegs: System F: Structures of the lipid nanoparticles with capped PEGylated lipids >> nanoparticles/lnp pegs: System G: Structure of the lipid nanoparticle with complete PEGylated lipids > Topologies - topology/DSPC.top - Parameters for the standard phospholipid from the CHARMM36 forcefield - topology/CHOL.top - Parameters for cholesterol from the CHARMM36 forcefield - topology/alc.itp, topology/alc.prm - Parametrization files of the PEG-ylated lipid ALC-0159 obtained from the CGenFF-Webserver - topology/alc neutral.itp - Parameters for the neutral aminolipid ALC-0315 obtained from the CGenFF-Webserver - topology/alc protonated.itp - Parameters for the protonated aminolipid ALC-0315 obtained from the CGenFF-Webserver - topology/modRNA.top - Parameters for the short modified mRNA strand. Uridine was replaced with N1-Methylpseudouridine. The parameters were not included in the standard CHARMM36 forcefield (version July 2020) and were manually added to the forcefield. - topology/ALC SHORT CORRECT IDX.itp - Parameters for the capped PEG-ylated lipid ALC-0159 -> Parameters were manually adapted to fit the shortened structure. - topology/charmm36-jul2020.ff - CHARMM36 forcefield parameters (version July 2020) with included parameters for N1-Methylpseudouridine. - topology/cgenff output - Output from the CGenFF-Webserver to parametrize the aminolipid (ALC-0315) and the PEGylated-lipid (ALC-0159) ", {"entities": [[406, 417, "STIME"], [420, 422, "STIME"], [493, 499, "STIME"], [501, 507, "STIME"], [512, 518, "STIME"], [692, 698, "STIME"], [719, 723, "MOL"], [766, 770, "MOL"], [782, 793, "MOL"], [880, 888, "STIME"], [1707, 1718, "STIME"], [1721, 1723, "STIME"], [2020, 2028, "FFM"], [2077, 2088, "MOL"], [2098, 2106, "FFM"], [2230, 2246, "SOFT"], [2341, 2357, "SOFT"], [2458, 2474, "SOFT"], [2546, 2553, "MOL"], [2572, 2594, "MOL"], [2645, 2684, "FFM"], [2920, 2928, "FFM"], [3000, 3022, "MOL"], [3067, 3083, "SOFT"]]}]]}